
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $47.9M | -- | -- | -$0.08 | -- |
08/08/2025 | Q2 | $47.7M | -- | -- | -$0.09 | -- |
05/30/2025 | Q1 | $51.1M | $45.2M | -$0.99 | -$0.15 | -$0.85 |
02/07/2025 | Q4 | $47M | $53.3M | -$0.79 | -$0.16 | -$0.63 |
11/08/2024 | Q3 | $47.8M | $46.2M | -$1.08 | -$0.24 | -$0.85 |
08/09/2024 | Q2 | $51.6M | $48.4M | -$1.17 | -$0.27 | -$0.90 |
05/30/2024 | Q1 | $53.2M | $54M | -$0.53 | -$0.23 | -$0.30 |
02/09/2024 | Q4 | $54.2M | $57.7M | -$1.92 | -$0.35 | -$1.58 |
11/09/2023 | Q3 | $60.7M | $51.9M | -$3.23 | -$0.84 | -$2.38 |
08/09/2023 | Q2 | $67.5M | $56.7M | -$0.51 | -$1.50 | $0.98 |
06/22/2023 | Q1 | $73.3M | $50.4M | -$9.46 | -$1.31 | -$8.15 |
02/09/2023 | Q4 | -- | $62.5M | -$3.93 | -- | -- |
11/09/2022 | Q3 | -- | $67.3M | -$4.75 | -- | -- |
08/05/2022 | Q2 | -- | $82.9M | -$41.01 | -- | -- |
05/27/2022 | Q1 | -- | $53M | -$11.52 | -- | -- |
02/09/2022 | Q4 | -- | $111.8M | -$2.22 | -- | -- |
11/05/2021 | Q3 | -- | $104.3M | -$0.24 | -- | -- |
08/06/2021 | Q2 | -- | $110.9M | $6.84 | -- | -- |
06/01/2021 | Q1 | -- | $117.1M | -$14.60 | -- | -- |
02/09/2021 | Q4 | -- | $117M | -$18.65 | -- | -- |
11/09/2020 | Q3 | -- | $101.5M | -$0.68 | -- | -- |
08/10/2020 | Q2 | -- | $79.7M | -$2.16 | -- | -- |
05/29/2020 | Q1 | -- | $80.5M | -$27.97 | -- | -- |
02/14/2020 | Q4 | -- | $93.7M | -$1.97 | -- | -- |
11/14/2019 | Q3 | -- | $58M | $1.89 | -- | -- |
08/14/2019 | Q2 | -- | $67.6M | -$4.04 | -- | -- |
06/20/2019 | Q1 | -- | $70.7M | -$7.37 | -- | -- |
01/14/2019 | Q4 | -- | $62.8M | -$2.87 | -- | -- |
11/14/2018 | Q3 | -- | $17.8M | -$11.63 | -- | -- |
08/14/2018 | Q2 | -- | $20.1M | -$3.10 | -- | -- |
03/31/2018 | Q1 | -- | $18.1M | -$2.61 | -- | -- |
12/31/2017 | Q4 | -- | $17.1M | $0.08 | -- | -- |
09/30/2017 | Q3 | -- | $14M | -$0.08 | -- | -- |
06/30/2017 | Q2 | -- | $11.8M | -$0.45 | -- | -- |
03/31/2017 | Q1 | -- | $11.1M | -$0.76 | -- | -- |
12/31/2016 | Q4 | -- | $7.3M | $0.15 | -- | -- |
09/30/2016 | Q3 | -- | $6.5M | $0.38 | -- | -- |
06/30/2016 | Q2 | -- | $5.4M | -$0.31 | -- | -- |
03/31/2016 | Q1 | -- | $3.7M | -$0.51 | -- | -- |
12/31/2015 | Q4 | -- | $2.6M | -$0.30 | -- | -- |
09/30/2015 | Q3 | -- | $1.9M | $0.38 | -- | -- |
Canopy Growth reported $45.2M worth of top line sales in its most recent quarter.
Canopy Growth announced earnings per share of -$0.99 which represents a miss of analyst forecast a -$0.15 per share.
Canopy Growth reported $7.3M that represents $0.05 per share over the last quarter.
Canopy Growth's earnings are forecast to decrease from -$3.99 per share to -$2.47 per share next year representing a decrease of -95.79%.
Canopy Growth's next earnings date is August 8, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.